Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000309039 | SCV000343222 | uncertain significance | not provided | 2016-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001089388 | SCV001083849 | likely benign | Mucolipidosis type IV | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Pars Genome Lab | RCV001089388 | SCV001652844 | likely benign | Mucolipidosis type IV | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411168 | SCV002670039 | likely benign | Inborn genetic diseases | 2022-09-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001089388 | SCV001461391 | uncertain significance | Mucolipidosis type IV | 2018-10-29 | no assertion criteria provided | clinical testing |